← All trials
NCT05123365
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 15, 2021
- Primary completion
- Nov 15, 2022
- Completion date
- Nov 15, 2025
- First posted
- Nov 17, 2021
- Last posted
- Nov 17, 2021
- Enrollment
- 27
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- University of California, IrvineLead sponsor
- University of California, IrvineReponsible party - principal investigator
- Chao Family Comprehensive Cancer CenterOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.